# Bioequivalence Study of Ritonavir Versus NORVIR in Healthy Chinese Subjects

> **NCT03302182** · PHASE1 · COMPLETED · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 96 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Ritonavir for cycle1 and NORVIR for cycle 2
- **DRUG:** NORVIR for cycle 1 and Ritonavir for cycle 2

## Key facts

- **NCT ID:** NCT03302182
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-23
- **Primary completion:** 2017-11-04
- **Final completion:** 2017-12-04
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2018-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03302182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03302182, "Bioequivalence Study of Ritonavir Versus NORVIR in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03302182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*